Important timelines for the study
| Parameter | A | B | p Value |
|---|---|---|---|
| Total ischaemic time (min) | 0.69 | ||
| Median | 245 | 260 | |
| IQR | 185–395 | 185–390 | |
| Time to pharmacoinvasive strategy (h) | 12:15 (4:30–23:40) | – | NA |
| Door-to-balloon time (min) | NA | ||
| Median | – | 80 | |
| IQR | – | 60–120 | |
| Door-to-needle time (min) | NA | ||
| Median | 47 | – | |
| IQR | 35–75 | – | |
NA, not applicable.